Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer

Lung Cancer

Volumn 84, Issue 1, 2014, Pages 79-85

  Go, Se Il ^a   Lee, Anna ^a   Lee, Un Seok ^a   Choi, Hye Jung ^a   Kang, Myung Hee ^a   Kang, Jung Hun ^a   Jeon, Kyung Nyeo ^a   Park, Mi Jung ^a   Kim, Seok Hyun ^b   Lee, Gyeong Won ^a,c  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Gyeongsang National University   (South Korea)

Author keywords

Deep vein thrombosis; Lung neoplasms; Lymphocytes; Neutrophils; Pulmonary thromboembolism

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FRUCTOSE BISPHOSPHATE; HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN; PROTHROMBIN; WARFARIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; VERY ELDERLY;

DEEP VEIN THROMBOSIS; LUNG NEOPLASMS; LYMPHOCYTES; NEUTROPHILS; PULMONARY THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BIOLOGICAL MARKERS; FEMALE; HUMANS; INCIDENCE; LEUKOCYTE COUNT; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84896737593     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.01.014     Document Type: Article

References (39)

1. Khorana A.A. Cancer-associated thrombosis: updates and controversies. Hematol Am Soc Hematol Educ Progr 2012, 2012:626-630.
2. Tesselaar M.E., Osanto S. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 2007, 13:362-367.
3. Blom J.W., Osanto S., Rosendaal F.R. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2004, 2:1760-1765.
4. Tagalakis V., Levi D., Agulnik J.S., Cohen V., Kasymjanova G., Small D. High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients. J Thorac Oncol 2007, 2:729-734.
5. Connolly G.C., Menapace L., Safadjou S., Francis C.W., Khorana A.A. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients. Clin Lung Cancer 2013, 14:713-718.
6. Huang H., Korn J.R., Mallick R., Friedman M., Nichols C., Menzin J. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study. J Thromb Thrombolysis 2012, 34:446-456.
7. Hicks L.K., Cheung M.C., Ding K., Hasan B., Seymour L., Le Maitre A., et al. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer 2009, 115:5516-5525.
8. Lee J.W., Cha S.I., Jung C.Y., Choi W.I., Jeon K.N., Yoo S.S., et al. Clinical course of pulmonary embolism in lung cancer patients. Respiration 2009, 78:42-48.
9. Franchini M., Montagnana M., Targher G., Manzato F., Lippi G. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. J Thromb Thrombolysis 2007, 24:29-38.
10. Kambas K., Mitroulis I., Ritis K. The emerging role of neutrophils in thrombosis - the journey of TF through NETs. Front Immunol 2012, 3:385.
11. Demers M., Krause D.S., Schatzberg D., Martinod K., Voorhees J.R., Fuchs T.A., et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci USA 2012, 109:13076-13081.
12. Toh E., Wilson J., Sebag-Montefiore D., Botterill I. Neutrophil-lymphocyte ratio (NLR) as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma (SCC) of the anus. Colorectal Dis 2013, [Epub ahead of print].
13. Szkandera J., Absenger G., Liegl-Atzwanger B., Pichler M., Stotz M., Samonigg H., et al. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer 2013, 108:1677-1683.
14. Lee S., Oh S.Y., Kim S.H., Lee J.H., Kim M.C., Kim K.H., et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer 2013, 13:350.
15. Chua W., Charles K.A., Baracos V.E., Clarke S.J. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011, 104:1288-1295.
16. Stotz M., Gerger A., Eisner F., Szkandera J., Loibner H., Ress A.L., et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013, 109:416-421.
17. Unal D., Eroglu C., Kurtul N., Oguz A., Tasdemir A. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis?. Asian Pac J Cancer Prev 2013, 14:5237-5242.
18. Sarraf K.M., Belcher E., Raevsky E., Nicholson A.G., Goldstraw P., Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009, 137:425-428.
19. Forget P., Machiels J.P., Coulie P.G., Berliere M., Poncelet A.J., Tombal B., et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol 2013, 20:650-660.
20. Tomita M., Shimizu T., Ayabe T., Nakamura K., Onitsuka T. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Anticancer Res 2012, 32:3535-3538.
21. Yao Y., Yuan D., Liu H., Gu X., Song Y. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother 2013, 62:471-479.
22. Cedres S., Torrejon D., Martinez A., Martinez P., Navarro A., Zamora E., et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol 2012, 14:864-869.
23. Lee Y., Kim S.H., Han J.Y., Kim H.T., Yun T., Lee J.S. Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. J Cancer Res Clin Oncol 2012, 138:2009-2016.
24. Gazi E., Bayram B., Gazi S., Temiz A., Kirilmaz B., Altun B., et al. Prognostic value of the neutrophil-lymphocyte ratio in patients with ST-elevated acute myocardial infarction. Clin Appl Thromb Hemost 2013, [Epub ahead of print].
25. Sen N., Afsar B., Ozcan F., Buyukkaya E., Isleyen A., Akcay A.B., et al. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis 2013, 228:203-210.
26. Gul M., Uyarel H., Ergelen M., Ugur M., Isik T., Ayhan E., et al. Predictive value of neutrophil to lymphocyte ratio in clinical outcomes of non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Clin Appl Thromb Hemost 2012, [Epub ahead of print].
27. Kaya M.G., Akpek M., Lam Y.Y., Yarlioglues M., Celik T., Gunebakmaz O., et al. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. Int J Cardiol 2013, 168:1154-1159.
28. Cho K.H., Jeong M.H., Ahmed K., Hachinohe D., Choi H.S., Chang S.Y., et al. Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2011, 107:849-856.
29. Folsom A.R., Lutsey P.L., Heckbert S.R., Cushman M. Serum albumin and risk of venous thromboembolism. Thromb Haemost 2010, 104:100-104.
30. Kroger K., Weiland D., Ose C., Neumann N., Weiss S., Hirsch C., et al. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 2006, 17:297-303.
31. Prandoni P., Falanga A., Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005, 6:401-410.
32. Massberg S., Grahl L., von Bruehl M.L., Manukyan D., Pfeiler S., Goosmann C., et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010, 16:887-896.
33. von Bruhl M.L., Stark K., Steinhart A., Chandraratne S., Konrad I., Lorenz M., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012, 209:819-835.
34. Cools-Lartigue J., Spicer J., McDonald B., Gowing S., Chow S., Giannias B., et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 2013, 123:3446-3458.
35. Demers M., Wagner D.D. Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology 2013, 2:e22946.
36. Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010, 107:15880-15885.
37. Kambas K., Mitroulis I., Apostolidou E., Girod A., Chrysanthopoulou A., Pneumatikos I., et al. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS ONE 2012, 7:e45427.
38. Pabinger I., Thaler J., Ay C. Biomarkers for prediction of venous thromboembolism in cancer. Blood 2013, 122:2011-2018.
39. Geng J.G. Interaction of vascular endothelial cells with leukocytes, platelets and cancer cells in inflammation, thrombosis and cancer growth and metastasis. Acta Pharmacol Sin 2003, 24:1297-1300.